References
References
"Lessons Learned From SARS," by Linda R. Greene, RN, MPS, CIC, and AnnMarie Pettis, RN, BSN, CIC, page 43.
1. http://www.cdc.gov/ncidod/sars/ic.htm
2. Ksiazek et al. NEJM 2003:348;1953
3. Revised U.S. Surveillance Case Definition for Severe Acute Respiratory Syndrome (SARS) and Update on SARS Cases --- United States and Worldwide, December 2003 Vol 52, No 49;1202 12/12/2003
4. http://www.who.int/csr/disease/avian_influenza/en/
5. http://www.cdc.gov/ncidod/sars/factsheet
6. Ibid.
7. Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus Yu etal NEJM 2004 350:1731-9
8. Outbreaks of Avian Influenza A (H5N1) in Asia and Interim Recommendations for Evaluation and Reporting of Suspected Cases --- United States, 2004 Vol 53, No 05;97 02/13/2004
9. http://www.fao.org/ag/againfo/subjects/en/health/diseases-cards/special_avian.html
10. Ibid.
11. http://www.cdc.gov/flu/professionals/infectioncontrol/resphygiene.htm
12. Seto WH, Tsang D, Yung RW et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361:1519-20.
13. Ibid.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
